Conference Recap
Conference Recap
Highlights in Early Breast Cancer From ESMO 2023
Highlights in early breast cancer from ESMO 2023 include 5-year results from KEYNOTE-522 in TNBC, pCR benefits in ER+/HER2-, and a genomic risk...
Conference Recap
Highlights in Metastatic Breast Cancer From ESMO 2023
New therapies, research, and management tools in metastatic breast cancer as reported at the ESMO 2023 Congress are discussed by Dr Ann Partridge...
Conference Recap
AVAHO 2023: Meeting the Challenges of Veterans' Healthcare
Conference Recap
AVAHO 2023 Takeaways: Elevating Cancer Care for Veterans
Conference Recap
AVAHO 2023: Innovations in Cancer Care Delivery
Conference Recap
AVAHO 2023: A New View of Women's Health and Clinician Wellness
Conference Recap
AVAHO 2023: Expanding Opportunities for Veteran Care
Conference Recap
AVAHO 2023: Exploring AI and Cancer Navigation for Veterans
Conference Recap
Follicular Lymphoma Highlights From ASH 2022
Follicular lymphoma highlights from ASH 2022 include a comparison of rituximab to watch-and-wait and updates on tazemetostat and mosunetuzumab, as...
Conference Recap
Chronic Lymphocytic Leukemia Highlights From ASH 2022
CLL treatments from ASH 2022 include pirtobrutinib in pretreated patients, zanubrutinib in relapsed/refractory disease, and frontline ibrutinib +...